Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases

by Kentaro Ishida, Peter Gee, Akitsu Hotta
Published 2015-10-01

Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy

by Peter Gee, Huaigeng Xu, Akitsu Hotta
Published 2017-01-01

Getting animated about routine data: co-producing a video and toolkit with young families

by Fiona Lugg-Widger, Jeremy Segrott, Peter Gee, Joyce Kenkre, Mike Robling
Published 2018-08-01

CRISPR-Cas3 induces broad and unidirectional genome editing in human cells

by Hiroyuki Morisaka, Kazuto Yoshimi, Yuya Okuzaki, Peter Gee, Yayoi Kunihiro, Ekasit Sonpho, Huaigeng Xu, Noriko Sasakawa, Yuki Naito, Shinichiro Nakada, Takashi Yamamoto, Shigetoshi Sano, Akitsu Hotta, Junji Takeda, Tomoji Mashimo
Published 2019-12-01

Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells.

by Joseph A Hollenbaugh, Peter Gee, Jonathon Baker, Jonathon Baker, Michele B Daly, Sarah M Amie, Jessica Tate, Natsumi Kasai, Yuka Kanemura, Dong-Hyun Kim, Brian M Ward, Yoshio Koyanagi, Baek Kim
Published 2013-01-01

Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping

by Peter Gee, Mandy S. Y. Lung, Yuya Okuzaki, Noriko Sasakawa, Takahiro Iguchi, Yukimasa Makita, Hiroyuki Hozumi, Yasutomo Miura, Lucy F. Yang, Mio Iwasaki, Xiou H. Wang, Matthew A. Waller, Nanako Shirai, Yasuko O. Abe, Yoko Fujita, Kei Watanabe, Akihiro Kagita, Kumiko A. Iwabuchi, Masahiko Yasuda, Huaigeng Xu, Takeshi Noda, Jun Komano, Hidetoshi Sakurai, Naoto Inukai, Akitsu Hotta
Published 2020-03-01